This inventor holds 1 USPTO granted patent. Top assignee: Kainos Medicine Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Changsun Yu: Innovator in Alpha-Synuclein Modulation
Introduction
Changsun Yu is a prominent inventor based in Yongin, South Korea. He has made significant contributions to the field of medical research, particularly in the modulation of alpha-synuclein, a protein associated with neurodegenerative diseases.
Latest Patents
Changsun Yu holds a patent titled "Modulators of Alpha-Synuclein." This patent represents his innovative approach to addressing the challenges posed by alpha-synuclein in medical science. He has 1 patent to his name, showcasing his commitment to advancing research in this critical area.
Career Highlights
Yu is currently employed at Kainos Medicine Inc., where he continues to develop groundbreaking solutions in the medical field. His work at Kainos Medicine Inc. reflects his dedication to improving patient outcomes through innovative research.
Collaborations
Throughout his career, Changsun Yu has collaborated with talented individuals such as Eunhee Kim and Jae Moon Lee. These collaborations have further enriched his research and contributed to the advancement of their shared goals in medical innovation.
Conclusion
Changsun Yu is a dedicated inventor whose work in alpha-synuclein modulation is paving the way for future advancements in medical research. His contributions are vital to understanding and potentially treating neurodegenerative diseases.